Share This Article:

Antigen Detection in Canine Blastomycosis: Comparison of Different Antibody-Antigen Combinations in Two Competitive ELISAs

Abstract Full-Text HTML XML Download Download as PDF (Size:96KB) PP. 110-114
DOI: 10.4236/ojmm.2012.23016    3,191 Downloads   5,376 Views   Citations

ABSTRACT

This present study was designed to evaluate four different Blastomyces dermatitidis antibody-antigen combinations (B5896 and T-58 antibodies and B5896 and WI-R antigens) for the detection of antigen in 36 urine specimens from dogs with blastomycosis using a standard indirect ELISA (STD) and a biotin-streptavidin ELISA (B-SA). The antigen detection sensitivity values ranged from 81% (B-SA: T-58 Ab + WI-R Ag) to 100% (STD and B-SA: B5896 Ab + WI-R Ag; B5896 Ab + B5896 Ag) with the antibody-antigen combinations in the two assays. Optimal detection was evidenced when the B5896 Ab was allowed to react with the urine specimens for 30 min at 37?C and then placed in the B-SA ELISA plates containing the B5896 Ag. The greatest absorbance value obtained with this antibody-antigen com-bination was 0.903 (range of 0.596 - 0.903) as compared to the control value of 1.246. The difference between the control absorbance and the test absorbance values was 0.343 which was considerably greater than the control-test values with the other combinations. This study thus showed that the results obtained in antigen detection assays are dependent upon the antibody used to react with the urine specimens as well as the antigen used in the enzyme immunoassay.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

D. Andrae, K. Birch, T. Bybee, T. Ritcher, J. Werth and G. Scalarone, "Antigen Detection in Canine Blastomycosis: Comparison of Different Antibody-Antigen Combinations in Two Competitive ELISAs," Open Journal of Medical Microbiology, Vol. 2 No. 3, 2012, pp. 110-114. doi: 10.4236/ojmm.2012.23016.

References

[1] A. F. DiSalvo, “Blastomycosis, in Topley and Wilson’s Microbiology and Microbial Infections,” 9th Edition, Arnold Publishers, London, 1998, pp. 337-355.
[2] J. A. McKinnell and P. G. Pappas, “Blastomycosis: New Insights into Diagnosis, Prevention, and Treatment,” Clinical Chest Medicine, Vol. 30, No. 2, 2009, pp. 227239. doi:10.1016/j.ccm.2009.02.003
[3] J. A. Smith and C. A. Kauffman, “Pulmonary Fungal Infections,” Respirology, Vol. 17, No. 6, 2012, pp. 913-926.
[4] J. A. Smith and C. A. Kauffman, “Blastomycosis,” Proceedings of the American Thoracic Society, Vol. 7, No. 3, 2010, pp. 173-180. doi:10.1513/pats.200906-040AL
[5] J. R. Bariola and K. S. Vyas, “Pulmonary Blastomycosis,” Seminars in Respiratory Critical Care Medicine, Vol. 32, No. 6, 2011, pp. 745-753. doi:10.1055/s-0031-1295722
[6] M. Saccente and G. L. Woods, “Clinical and Laboratory Update on Blastomycosis,” Clinical Microbiology Reviews, Vol. 23, No. 2, 2010, pp. 367-381. doi:10.1128/CMR.00056-09
[7] D. Spector, A. M. Legendre, J. Wheat, D. Bemis, B. Rohrbach, J. Taboada and M. Durkin, “Antigen and Antibody Testing for the Diagnosis of Blastomycosis in Dogs,” Journal of Veterinary Internal Medicine, Vol. 22, No. 4, 2008, pp. 839-843. doi:10.1111/j.1939-1676.2008.0107.x
[8] B. S. Klein, R. A. Squires, J. K. Lloyd, D. R. Ruge and A. M. Legendre, “Canine Antibody Response to Blastomyces dermatitidis WI-1 Antigen,” American Journal of Veterinary Research, Vol. 61, No. 5, 2000, pp. 554-558.
[9] K. S. Vyas, J. R. Bariola and R. W. Bradsher, “Advances in the Serodiagnosis of Blastomycosis,” Current Fungal Infection Reports, Vol. 2, No. 4, 2008, pp. 227-231. doi:10.1007/s12281-008-0033-z
[10] S. M. Johnson and G. M. Scalarone, “Preparation and ELISA Evaluation of Blastomyces dermatitidis Yeast Phase Lysate Antigens,” Diagnostic Microbiology and Infectious Diseases, Vol. 11, No. 2, 1989, pp. 81-86. doi:10.1016/0732-8893(88)90076-4
[11] J. F. Shurley, A. M. Legendre and G. M. Scalarone, “Blastomyces dermatitidis Antigen Detection in Urine Specimens from Dogs with Blastomycosis Using a Competitive Binding Inhibition ELISA,” Mycopathologia, Vol. 160, No. 2, 2005, pp. 137-142. doi:10.1007/s11046-005-3153-9
[12] C. M. Sestero and G. M. Scalarone, “Detection of IgG and IgM in Sera from Canines with Blastomycosis Using Eight Blastomyces dermatitidis Yeast Phase Lysate Antigens,” Mycopathologia, Vol. 162, No. 1, 2006, pp. 33-37. doi:10.1007/s11046-006-0028-7
[13] W. O. Hatch and G. M. Scalarone, “Comparison of Colorimetric and Chemiluminescent ELISAs for the Detection of Antibodies to Blastomyces dermatitidis,” Journal of Medical and Biological Sciences, Vol. 3, No. 1, 2009, pp. 1-6.
[14] M. Durkin, L. Estok, D. Hospenthal, N. Crum-Cianflone, S. Swartzentruber, E. Hackett and L. J. Wheat, “Detection of Coccidioides Antigenemia Following Dissociation of Immune Complexes,” Clinical and Vaccine Immunology, Vol. 16, No. 10, 2009, pp. 1453-1456. doi:10.1128/CVI.00227-09
[15] J. R. Bariola, C. A. Hage, M. Durkin, E. Bensadoun, P. O. Gubbins, L. J. Wheat and R. W. Bradsher, “Detection of Blastomyces dermatitidis Antigen in Patients with Newly Diagnosed Blastomycosis,” Diagnostic Microbiology and Infectious Diseases, Vol. 69, No. 2, 2011, pp. 187-191. doi:10.1016/j.diagmicrobio.2010.09.015
[16] P. Connolly, C. A. Hage, J. R. Bariola, E. Bensadoun, M. Rodgers, R. W. Bradsher Jr. and L. J. Wheat, “Blastomyces dermatitidis Antigen Detection by Quantitative Enzyme Immunoassay,” Clinical Vaccine Immunology, Vol. 19, No. 1, 2012, pp. 53-56. doi:10.1128/CVI.05248-11
[17] D. R. Allton, R. G. Rivard, P. A. Connolly, S. McCall, M. M. Durkin, T. M. Boyd, J. P. Flanagan, L. J. Wheat and D. R. Hospenthal, “Detection of Latin American Strains of Histoplasma in a Murine Model by Use of a Commercially Available Antigen Test,” Clinical and Vaccine Immunology, Vol. 17, No. 5, 2010, pp. 802-806. doi:10.1128/CVI.00043-10
[18] C. A. Hage, J. A. Ribes, N. L. Wengenack, L. M. Baddour, M. Assi, D. S. McKinsey, K. Hammoud, D. Alapat, N. E. Babady, M. Parker, De A. Fuller, A. Noor, T. E. Davis, M. Rodgers, P. A. Connolly, B. El Haddab and L. J. Wheat, “A Multicenter Evaluation of Tests for Diagnosis of Histoplasmosis,” Clinical Infectious Diseases, Vol. 53, No. 5, 2011, pp. 448-454. doi:10.1093/cid/cir435
[19] H. B. Levine, G. M. Scalarone and S. D. Chaparas, “Preparation of Fungal Antigens and Vaccines: Studies on Coccidioides immitis and Histoplasma capsulatum,” Contributions to Microbiology and Immunology, Vol. 3, 1977, pp. 106-125.
[20] H. B. Levine, G. M. Scalarone, G. D. Campbell, J. R. Graybill, P. C. Kelly and S. D. Chaparas, “Histoplasmin-CYL, a Yeast Phase Reagent in Skin Test Studies in Humans,” The American Review of Respiratory Diseases, Vol. 119, No. 4, 1979, pp. 629-636.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.